Search
for
Sort by
Research 121–150 of 1000+
- Stem Cell Use to Treat Dermatological Disorders
- Unlocking the Power of Light on the Skin: A Comprehensive Review on Photobiomodulation
- Th1/Th2 PB balance and CD200 expression of patients with active severe alopecia areata
- Stem Cells in Regenerative Medicine: A Journey from Adult Stem Cells to Induced Pluripotent Cells
- A State-of-the-Art Overview on (Epi)Genomics and Personalized Skin Rejuvenating Strategies
- Drug-induced changes in hair growth
- Recent advances on skin‐resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti‐aging and cancer therapies
- Recurrent implantation failure: A comprehensive summary from etiology to treatment
- Cell death in the skin
- Update on the dermatologic use of systemic glucocorticosteroids
- Poster Presentations
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications
- Case Report: Dupilumab induced sustained complete remission in a child with severe alopecia areata and markedly elevated IgE
- Atypical presentation of Acrodermatitis enteropathica in a child: later onset with life-threatening severe extensive dermatitis and septic shock
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Scar Inhibition in Wound Healing: Mechanisms, Design, and Recent Advances
- A Case Report of Discoid Lupus Erythematosus Mimicking Skin Infection
- Cutaneous drug reactions
- Immune globulin
- Platelet Immune Interactions, Lifespan, and Senescence
- 5. HIV, Fungal and Infectious Diseases
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Adverse Cutaneous Reactions to Antidepressants
- The role of lymphocytes in the development and treatment of alopecia areata
- How to diagnose a lipodystrophy syndrome
- Idiopathic CD4+ T-lymphocytopenia
- The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites
- Management of Toxicities of Targeted Therapies
- Dermatological Drugs, Topical Agents, and Cosmetics